Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.07

(0.15%)

FLWS

$4.45

(-3.47%)

ACCO

$3.91

(-2.01%)

ARLP

$25.2

(-0.24%)

AUIAF

$0.19

(-9.81%)

AZZ

$100.75

(-4.9%)

BTBT

$4.02

(-0.5%)

BTM

$3.33

(-0.3%)

CVKD

$14.19

(1.65%)

LCE:CA

$0.34

(-2.9%)

COCP

$1.22

(-2.4%)

CDRO

$6.81

(0.15%)

CVGI

$1.67

(-2.91%)

LODE

$3.79

(5.87%)

CMTL

$3.09

(6.19%)

CNDT

$2.67

(-3.61%)

CXW

$18.31

(-2.35%)

CMLS

$0.14

(-7.77%)

DRCT

$0.36

(22.16%)

DLHC

$5.7

(0.71%)

SSP

$2.34

(-3.31%)

ELDN

$2.98

(3.83%)

EVC

$2.21

(-3.07%)

EDRY

$12.4

(-0.8%)

ESEA

$56.23

(0.3%)

FAT

$2.06

(-1.2%)

RAIL

$9.75

(-2.99%)

GDEV

$33.19

(-6.24%)

GOVX

$0.6

(2.93%)

GOCO

$4.45

(-4.3%)

GHM

$57.86

(2.72%)

GLDD

$11.61

(-2.27%)

GYRE

$7.27

(-0.41%)

HMENF

$1.56

(-1.29%)

III

$5.52

(-2.65%)

IPOOF

$9.31

(-2.72%)

KELYA

$12.75

(-2%)

KTOS

$98.55

(-6.74%)

LUCK

$9.93

(-1.59%)

MAIA

$1.72

(-4.97%)

MGROF

$0.49

(3.87%)

NTRB

$7.91

(-6.94%)

OCGN

$1.83

(2.23%)

PERF

$2.02

(0.5%)

QMCI

$0.17

(7.43%)

RGP

$4.75

(-4.04%)

SGA

$12.7

(0.36%)

SHWZ

(219900%)

SHIP

$8.05

(-2.07%)

SLQT

$1.93

(-2.03%)

SKYX

$1.2

(-7.69%)

SNAL

$1.11

(-1.19%)

GEO

$18.25

(-1.67%)

ODP

$27.73

(-0.11%)

TNXP

$22.54

(0.22%)

TSQ

$6.43

(1.42%)

TZOO

$9.94

(-1.09%)

UNCY

$4.73

(-0.84%)

VVX

$58.35

(-2.67%)

VNCE

$3.05

(-2.24%)

XELB

$2.05

(0.49%)

ZOMDF

$0.07

(0.15%)

FLWS

$4.45

(-3.47%)

channelchek-in

‌

10/9/2025

Novo Nordisk Acquires Akero Therapeutics in $5.2 Billion Deal to Bolster MASH Treatment Pipeline

Novo Nordisk is making another bold move in the metabolic disease space with its latest agreement to acquire Akero Therapeutics for up to $5.2 billion, marking one of the year’s largest biotech takeovers. The deal strengthens Novo Nordisk’s expanding presence in liver and metabolic disorders, while delivering significant value to Akero’s shareholders.

3 min read